Перевести на Переведено сервисом «Яндекс.Перевод»

Acorda Therapeutics, Inc.

Country
USA
Краткое название
Acorda Therapeutics, Inc.
Headquarters
420 Saw Mill River Road
Members of the board

Ron Cohen, M.D. — President & Chief Executive Officer
Thomas C. Aquilina, M.D. — VP of Drug Safety & Risk Management
Andrew R. Blight, Ph.D. — Chief Scientific Officer
Jennifer Burstein, M.B.A., CPA — VP, Finance
Anthony O. Caggiano, M.D., Ph.D. — VP, R&D
Enrique J. Carrazana, M.D. — Chief Medical Officer
Kerry Clem — VP, Sales
Denise Duca, Ed. M. — SVP, Human Resources
Herbert Raymond Henney III, Pharm.D. — VP, Medical Affairs
Elizabeth Keating — VP, Marketing
Ruhi Khan, M.B.A. — VP, Business Development
David Lawrence, M.B.A. — Chief Financial Officer
Bonnie M. Pappacena — VP, Quality
Adrian Rabinowicz, M.D., FAAN — SVP, Medical Affairs
Kent Rogers, M.B.A. — VP, Managed Markets
Lauren Sabella — EVP, Commercial Development
Tierney Saccavino — SVP, Corporate Communications
Brian Walter, Ph.D. — VP, Regulatory Affairs
Jane Wasman, J.D. — President, International & General Counsel

Categories medicine
Neurology
Stage of the project
Production
Disease
Multiocular sclerosis
Ticker
ACOR
Current owners

Ron Cohen, M.D.
Barry Greene
Peder K. Jensen, M.D.
John P. Kelley
Sandra Panem, Ph.D.
Lorin J. Randall
Steven M. Rauscher
Ian F. Smith

Assets
1.4700
Technology
Services, Technologies, Pharmaceuticals, Chemistry